Gill, K;
Horsley, H;
Swamy, S;
Khasriya, R;
Malone-Lee, J;
(2021)
A prospective observational study of urinary cytokines and inflammatory response in patients with Overactive Bladder Syndrome.
BMC Urology
, 21
(1)
, Article 39. 10.1186/s12894-021-00809-4.
Preview |
Text
s12894-021-00809-4.pdf - Published Version Download (1MB) | Preview |
Abstract
Background Contemporary studies have discredited the methods used to exclude urinary tract infection (UTI) when treating overactive bladder (OAB). Thus we must revisit the OAB phenotype to check that UTI has not been overlooked. Aims To examine the differences in urinary cytokines IL6 and lactoferrin in OAB patients compared to controls, with references to microscopy of urine and enhanced quantitative urine culture. Methods A blinded, prospective cohort study with normal controls using six repeated measures, achieved two-monthly, over 12 months. Results The differences between patients and controls in urine IL6 (F = 49.0, p < .001) and lactoferrin (F = 228.5, p < .001) were significant and of a magnitude to have clinical implications. These differences were for lactoferrin correlated to symptoms (9.3, p = .003); for both to pyuria (IL6 F = 66.2, p < .001, Lactoferrin F = 73.9, p < .001); and for IL6 microbial abundance (F = 5.1, p = .024). The pathological markers had been missed by urinary dipsticks and routine MSU culture. Conclusion The OAB phenotype may encompass patients with UTI that is being overlooked because of the failure of standard screening methods.
| Type: | Article |
|---|---|
| Title: | A prospective observational study of urinary cytokines and inflammatory response in patients with Overactive Bladder Syndrome |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1186/s12894-021-00809-4 |
| Publisher version: | https://doi.org/10.1186/s12894-021-00809-4 |
| Language: | English |
| Additional information: | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Urology & Nephrology |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Renal Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10125055 |
Archive Staff Only
 |
View Item |
